• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[尖端扭转型室速。关于54例病例]

[Torsade de pointes. Apropos of 54 cases].

作者信息

Milon D, Daubert J C, Saint-Marc C, Gouffault J

出版信息

Ann Fr Anesth Reanim. 1982;1(5):513-20. doi: 10.1016/s0750-7658(82)80094-4.

DOI:10.1016/s0750-7658(82)80094-4
PMID:7184347
Abstract

A retrospective study of 54 torsades de pointe cases in a cardiology department enabled us to specify the main characteristics of this serious arrythmia often observed in intensive care units: --the diagnostic criteria: more than the pattern of tachycardia attack, late ventricular premature beats and particularly QT prolongation are necessary for proper diagnosis. These two criteria allow us to differentiate between torsades de pointe and multiform ventricular tachycardia with similar morphology especially in acute myocardial ischaemia; --their clinical repercussion: the shortness of circulatory arrest related to the spontaneous end of the arrythmia explains that the torsades de pointe often result in short faintings. Nevertheless, they may degenerate into ventricular fibrillation (17 p. 100) which, in cases of recurrence, induced four deaths in this study; --there are many possible aetiologies often associated (30 p. 100) in the same patient. Their research must be exhaustive in each case. The chronic bradycardias especially the atrioventricular blocks of two or three degree whether continuous or not are often responsible (57 p. 100). Then, the metabolic disorders, essentially hypokalaemia and constant drug administration (antiarrythmic agents belonging to group I of Vaughan William's classification, some antianginal drugs, vasodilatator drugs) are often chief causative agents. Other aetiologies are rare. In 9 p. 100 of cases, no aetiological factor is found; --the best treatment is to suppress aetiological factors, to stop the administration of antiarrhythmic drugs; torsades de pointe must be controlled by increasing the heart rate; pace maker stimulation is the best way of making QT shorter and thus of synchronizing ventricular depolarization.

摘要

对某心内科54例尖端扭转型室速病例进行的一项回顾性研究,使我们能够明确这种在重症监护病房中经常观察到的严重心律失常的主要特征:——诊断标准:除心动过速发作模式外,室性早搏晚期,尤其是QT间期延长,对于正确诊断是必要的。这两个标准使我们能够区分尖端扭转型室速和形态相似的多形性室性心动过速,尤其是在急性心肌缺血时;——它们的临床影响:心律失常自发终止导致的循环骤停时间短暂,这解释了尖端扭转型室速常导致短暂晕厥。然而,它们可能恶化为心室颤动(100例中有17例),在本研究中,复发情况下有4例死亡;——同一患者常有多种可能的病因(100例中有30例)。在每种情况下,对病因的排查都必须详尽。慢性心动过缓,尤其是二度或三度房室传导阻滞,无论是否持续,往往是病因(100例中有57例)。其次,代谢紊乱,主要是低钾血症和持续用药(属于Vaughan William分类I组的抗心律失常药物、一些抗心绞痛药物、血管扩张药物)往往是主要病因。其他病因则较为罕见。100例中有9例未发现病因;——最佳治疗方法是消除病因,停止使用抗心律失常药物;必须通过提高心率来控制尖端扭转型室速;起搏器刺激是使QT间期缩短从而使心室去极化同步的最佳方法。

相似文献

1
[Torsade de pointes. Apropos of 54 cases].[尖端扭转型室速。关于54例病例]
Ann Fr Anesth Reanim. 1982;1(5):513-20. doi: 10.1016/s0750-7658(82)80094-4.
2
[Torsades de pointe. Apropos of 60 cases].[尖端扭转型室速。关于60例病例]
Ann Cardiol Angeiol (Paris). 1985 Jun;34(6):381-8.
3
[Helicoid ventricular tachycardia, torsade de pointes, in acute myocardial infarction].[急性心肌梗死中的螺旋形室性心动过速、尖端扭转型室性心动过速]
Arch Inst Cardiol Mex. 1983 May-Jun;53(3):237-45.
4
Drug-induced torsade de pointes.药物性尖端扭转型室性心动过速
Clin Pharm. 1985 Nov-Dec;4(6):675-90.
5
"Torsades de pointe": a distinct entity of ventricular arrhythmia?“尖端扭转型室性心动过速”:一种独特的室性心律失常类型?
Acta Cardiol. 1978;33(3):167-84.
6
[Sotalol-induced torsades de pointe in the conscious dog with atrioventricular block. Role of hypokalemia].[索他洛尔诱发有意识的房室传导阻滞犬的尖端扭转型室性心动过速。低钾血症的作用]
Arch Mal Coeur Vaiss. 1988 Sep;81(9):1117-24.
7
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.女性作为与心血管药物相关的尖端扭转型室速的一个危险因素。
JAMA. 1993 Dec 1;270(21):2590-7. doi: 10.1001/jama.270.21.2590.
8
Torsade de pointe. Report of 18 cases.尖端扭转型室性心动过速。18例报告。
J Med Liban. 1993;41(2):62-8; discussion 68-9.
9
[QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].[米安色林治疗期间的QT间期延长和尖端扭转型室性心动过速。鉴别诊断和治疗方面]
Dtsch Med Wochenschr. 2001 Dec 7;126(49):1396-400. doi: 10.1055/s-2001-18880.
10
[Torsades de pointes initiated by slow ventricular stimulation].[缓慢心室刺激引发的尖端扭转型室性心动过速]
Arch Mal Coeur Vaiss. 1983 Aug;76(8):918-24.

引用本文的文献

1
Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval).酪氨酸激酶抑制剂的心血管安全性:特别关注心脏复极(QT 间期)。
Drug Saf. 2013 May;36(5):295-316. doi: 10.1007/s40264-013-0047-5.
2
Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter?药物引起的 QT 间期延长:全面 QT 研究人群的种族是否重要?
Br J Clin Pharmacol. 2013 Feb;75(2):347-58. doi: 10.1111/j.1365-2125.2012.04415.x.
3
Development of neuroleptic agents: pharmacogenetics and current safety issues of regulatory concern.
抗精神病药物的发展:药物遗传学及当前监管关注的安全性问题
Dialogues Clin Neurosci. 2002 Dec;4(4):449-62. doi: 10.31887/DCNS.2002.4.4/rshah.
4
QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel.美沙酮维持治疗中的 QT 间期筛查:美国卫生与公众服务部专家小组的报告。
J Addict Dis. 2011 Oct;30(4):283-306. doi: 10.1080/10550887.2011.610710.
5
Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.药物诱导的尖端扭转型室性心动过速的药物遗传学方面:改善临床药物开发和处方的潜在工具。
Drug Saf. 2004;27(3):145-72. doi: 10.2165/00002018-200427030-00001.
6
The significance of QT interval in drug development.QT间期在药物研发中的意义。
Br J Clin Pharmacol. 2002 Aug;54(2):188-202. doi: 10.1046/j.1365-2125.2002.01627.x.